Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293238 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Knee Injections in Musculoskeletal Medicine
A NA study of Knee Osteoarthritis, sponsored by Andrews Research & Education Foundation.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT03293238: Completed NA study of Knee Osteoarthritis, sponsored by Andrews Research & Education Foundation.
NCT03293238 is a NA study of Knee Osteoarthritis that has completed, run by Andrews Research & Education Foundation. The registered enrollment target is 63 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03293238, a NA study of Knee Osteoarthritis, has completed, sponsored by Andrews Research & Education Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the accuracy and patient reported outcomes between four different techniques used to perform a knee injection.
Primary Outcome
To assess presence or absence of contrast medium within the target knee joint as determined by a blinded radiologist. If contrast medium could be observed in the joint then the injection was considered a success.
Conditions Studied
Interventions
- PROCEDURE Joint line ultrasound
- PROCEDURE Joint line landmark
- PROCEDURE Suprapatellar ultrasound guided
- PROCEDURE Suprapatellar Landmark
Study Locations (1)
Florida
- Andrews Research & Education Foundation - Gulf Breeze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2011-11-03 |
| Est. Completion | 2018-02 |
| Phase | NA |
What the finished NCT03293238 record still lists
NCT03293238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 4 interventions - of which Joint line ultrasound is the first listed.
NCT03293238 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03293238 about?
NCT03293238 is a clinical study titled "Ultrasound Guided Knee Injections in Musculoskeletal Medicine". This study will compare the accuracy and patient reported outcomes between four different techniques used to perform a knee injection.
What is the current status of trial NCT03293238?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2011-11-03. Estimated completion is 2018-02.
What conditions does trial NCT03293238 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT03293238?
The interventions under investigation include: Joint line ultrasound (PROCEDURE), Joint line landmark (PROCEDURE), Suprapatellar ultrasound guided (PROCEDURE), Suprapatellar Landmark (PROCEDURE).
Who is sponsoring clinical trial NCT03293238?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03293238 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03293238's enrollment target sits among peer trials
63 60th of 101 higher than 42 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Knee Biofeedback Rehabilitation Through Game Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI